Adjunct Associate Professor of Pharmaceutical Sciences
BA, Cell Biology and Industrial Chemistry, University of Northern Colorado
PhD, Pharmacology and Toxicology, University of Arizona
• Instructor: PHPT 727, Integrated Pharmacotherapeutics IV: GI-Pulmonary
Dr. Sandoval's current research is focused on the evaluation of novel somatostatin receptor agonists for treatment of learning and memory disorders. Somatostatin is involved in learning and memory processing within the central nervous system, and also mediates the enzymatic breakdown of beta-amyloid, a major protein involved in the progression of Alzheimer's disease. Use of receptor subtype specific somatostatin agonists may provide an effective manner by which to treat individuals suffering from Alzheimer's disease. Dr. Sandoval also conducts research on the impact of menopause and estrogen replacement therapies on the structure and function of the blood-brain barrier (microvasculature of the brain). Alterations within the blood-brain barrier, as a component of aging, menopause and estrogen replacement therapies, may directly contribute to the exacerbation of stroke outcomes.